World Library  
Flag as Inappropriate
Email this Article


Article Id: WHEBN0005116280
Reproduction Date:

Title: Urocortin  
Author: World Heritage Encyclopedia
Language: English
Subject: Corticotropin-releasing factor family, SNAP-94847, Meclinertant, ATC-0175, SNAP-7941
Publisher: World Heritage Encyclopedia


Rendering based on PDB .
Available structures
PDB Ortholog search: PDBe, RCSB
Symbols  ; UI; UROC
External IDs GeneCards:
RNA expression pattern
Species Human Mouse
RefSeq (mRNA)
RefSeq (protein)
Location (UCSC)
PubMed search

Urocortin is a protein that in humans is encoded by the UCN gene.[1][2][3]


  • Function 1
  • Interactions 2
  • References 3
  • Further reading 4


This gene is a member of the sauvagine/corticotropin-releasing factor/urotensin I family. It is structurally related to the corticotropin-releasing factor (CRF) gene and the encoded product is an endogenous ligand for CRF type 2 receptors. In the brain, it may be responsible for the effects of stress on appetite. In spite of the gene family name similarity, the product of this gene has no sequence similarity to urotensin II.[3]

Urocortin is a potent anorexigenic peptide of 40 amino acids that induces fed-like motor activity when administered centrally or peripherally in fasted animals. Urocortin belongs to the corticotropin-releasing factor (CRF) family that includes CRF, urotensin I, sauvagine, urocortin II and urocortin III. Urocortin is also a potent and long-lasting hypotensive agent and increases coronary blood flow.


Urocortin has been shown to interact with Corticotropin releasing hormone receptor 1.[4][5]


  1. ^ Zhao L, Donaldson CJ, Smith GW, Vale WW (April 1999). "The structures of the mouse and human urocortin genes (Ucn and UCN)". Genomics 50 (1): 23–33.  
  2. ^ Tsarev OB (July 1977). "[Dynamics of matrix synthesis in molecular biophysics. II. Principle of insertability and the single-valued solution of feedback tasks]". Biofizika 22 (2): 197–200.  
  3. ^ a b "Entrez Gene: UCN urocortin". 
  4. ^ Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM, Vale WW (May 1996). "Cloning and characterization of human urocortin".  
  5. ^ Gottowik J, Goetschy V, Henriot S, Kitas E, Fluhman B, Clerc RG, Moreau JL, Monsma FJ, Kilpatrick GJ (October 1997). "Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin". Neuropharmacology 36 (10): 1439–46.  

Further reading

  • Inui A, Asakawa A, Bowers CY, Mantovani G, Laviano A, Meguid MM, Fujimiya M (Mar 2004). "Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ". FASEB J 18 (3): 439–56.  
  • Huang Y, Yao XQ, Lau CW, Chan YC, Tsang SY, Chan FL (Mar 2004). "Urocortin and cardiovascular protection". Acta Pharmacol Sin. 25 (3): 257–65. 
  • Takahashi, Kazuhiro (2004). "Translational medicine in fish-derived peptides: From fish endocrinology to human physiology and diseases". Endocrine Journal (Kyoto, Japan) 51 (1): 1–17.  
  • Adachi T, Schamel WW, Kim KM, Watanabe T, Becker B, Nielsen PJ, Reth M (1996). "The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence.". EMBO J. 15 (7): 1534–41.  
  • Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Totsune K, Takahashi K, Suzuki H, Nagura H, Yoshimi T (1997). "Urocortin expression in human pituitary gland and pituitary adenoma.". J. Clin. Endocrinol. Metab. 82 (11): 3842–50.  
  • Gottowik J, Goetschy V, Henriot S, Kitas E, Fluhman B, Clerc RG, Moreau JL, Monsma FJ, Kilpatrick GJ (1998). "Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.". Neuropharmacology 36 (10): 1439–46.  
  • Bamberger CM, Wald M, Bamberger AM, Ergün S, Beil FU, Schulte HM (1998). "Human lymphocytes produce urocortin, but not corticotropin-releasing hormone.". J. Clin. Endocrinol. Metab. 83 (2): 708–11.  
  • Takahashi K, Totsune K, Sone M, Murakami O, Satoh F, Arihara Z, Sasano H, Iino K, Mouri T (1998). "Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain.". Peptides 19 (4): 643–7.  
  • Iino K, Sasano H, Oki Y, Andoh N, Shin RW, Kitamoto T, Takahashi K, Suzuki H, Tezuka F, Yoshimi T, Nagura H (1999). "Urocortin expression in the human central nervous system.". Clin. Endocrinol. (Oxf) 50 (1): 107–14.  
  • Watanabe F, Oki Y, Ozawa M, Masuzawa M, Iwabuchi M, Yoshimi T, Nishiguchi T, Iino K, Sasano H (1999). "Urocortin in human placenta and maternal plasma.". Peptides 20 (2): 205–9.  
  • Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J (2000). "The skin produces urocortin.". J. Clin. Endocrinol. Metab. 85 (2): 815–23.  
  • Muramatsu Y, Fukushima K, Iino K, Totsune K, Takahashi K, Suzuki T, Hirasawa G, Takeyama J, Ito M, Nose M, Tashiro A, Hongo M, Oki Y, Nagura H, Sasano H (2001). "Urocortin and corticotropin-releasing factor receptor expression in the human colonic mucosa.". Peptides 21 (12): 1799–809.  
  • Muramatsu Y, Sugino N, Suzuki T, Totsune K, Takahashi K, Tashiro A, Hongo M, Oki Y, Sasano H (2001). "Urocortin and corticotropin-releasing factor receptor expression in normal cycling human ovaries.". J. Clin. Endocrinol. Metab. 86 (3): 1362–9.  
  • Hsu SY, Hsueh AJ (2001). "Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.". Nat. Med. 7 (5): 605–11.  
  • Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW (2001). "Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.". Proc. Natl. Acad. Sci. U.S.A. 98 (13): 7570–5.  
  • Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H (2002). "Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart.". J. Clin. Endocrinol. Metab. 87 (1): 340–6.  
  • Florio P, Arcuri F, Ciarmela P, Runci Y, Romagnoli R, Cintorino M, Di Blasio AM, Petraglia F (2002). "Identification of urocortin mRNA and peptide in the human endometrium.". J. Endocrinol. 173 (2): R9–14.  
  • Arcuri F, Cintorino M, Florio P, Floccari F, Pergola L, Romagnoli R, Petraglia F, Tosi P, Teresa Del Vecchio M (2002). "Expression of urocortin mRNA and peptide in the human prostate and in prostatic adenocarcinoma.". Prostate 52 (3): 167–72.  
  • Ikeda K, Tojo K, Oki Y, Nakao K (2002). "Urocortin has cell-proliferative effects on cardiac non-myocytes.". Life Sci. 71 (16): 1929–38.  

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.